RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Revenue

In the year 2025, RedHill Biopharma had annual revenue of $286.00K. RedHill Biopharma had revenue of $-3.79M in the half year ending December 31, 2025.

• Revenue (ttm): $286.00K
• Revenue Growth: -95.13%
• P/S Ratio: 17.52
• Revenue / Employee: $22,000
• Employees: 13
• Market Cap: 5.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	286.00K	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	61.80M	-23.96M	-27.94%
Dec 31, 2021	85.76M	21.40M	33.25%
Dec 31, 2020	64.36M	58.07M	923.03%
Dec 31, 2019	6.29M	-2.07M	-24.75%
Dec 31, 2018	8.36M	4.35M	108.63%
Dec 31, 2017	4.01M	3.91M	3,867.33%
Dec 31, 2016	101.00K	98.00K	3,266.67%
Dec 31, 2015	3.00K	-7.01M	-99.96%
Dec 31, 2014	7.01M	7.00M	58,350.00%
Dec 31, 2013	12.00K	-4.00K	-25.00%
Dec 31, 2012	16.00K	-7.00K	-30.43%
Dec 31, 2011	23.00K	-	-
Dec 31, 2010	-	-	-

Data Source: Fiscal.ai Last updated: Apr 10, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 23, 2026

Data Sources Report a data error